Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
NCT01468337Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Oct 2011
- Primary completion
- Nov 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in Central Serous Chorioretinopathy (CSCR), sponsored by National Eye Institute. Started Oct 2011; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT01468337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468337.